These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 9616216)

  • 21. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
    Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-2 pathway blocking in combination with anti-CD154 synergistically establishes mixed macrochimerism with limited dose of bone marrow cells and prolongs skin graft survival in mice.
    Lee JH; Ha J; Kim SH; Kim SJ
    J Korean Med Sci; 2006 Dec; 21(6):1005-11. PubMed ID: 17179677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
    Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
    Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4.
    Nicolls MR; Coulombe M; Yang H; Bolwerk A; Gill RG
    J Immunol; 2000 Apr; 164(7):3627-34. PubMed ID: 10725719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
    Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
    Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.
    Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z
    Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
    Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of donor-specific transfusion sources: unique failure of bone marrow cells to induce prolonged skin allograft survival with anti-CD154 monoclonal antibody.
    Markees TG; Pearson T; Cuthbert A; Pearson AL; Shultz LD; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    Transplantation; 2004 Dec; 78(11):1601-8. PubMed ID: 15591948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
    J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade.
    Turgeon NA; Iwakoshi NN; Phillips NE; Meyers WC; Welsh RM; Greiner DL; Mordes JP; Rossini AA
    J Surg Res; 2000 Sep; 93(1):63-9. PubMed ID: 10945944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion.
    Kimura F; Gotoh M; Tanaka T; Luo Z; Miyazaki J; Uede T; Monden M; Miyasaka M
    Diabetologia; 2002 Jun; 45(6):831-40. PubMed ID: 12107727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic islet xenograft tolerance after short-term costimulation blockade is associated with increased CD4+ T cell apoptosis but not immune deviation.
    Lehnert AM; Yi S; Burgess JS; O'Connell PJ
    Transplantation; 2000 Mar; 69(6):1176-85. PubMed ID: 10762224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.
    Coley SM; Ford ML; Hanna SC; Wagener ME; Kirk AD; Larsen CP
    J Immunol; 2009 Jan; 182(1):225-33. PubMed ID: 19109153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand.
    Markees TG; Phillips NE; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    Transplantation; 1997 Jul; 64(2):329-35. PubMed ID: 9256196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-gamma is not a universal requirement for islet allograft survival.
    Nicolls MR; Coulombe M; Diamond AS; Beilke J; Gill RG
    Transplantation; 2002 Aug; 74(4):472-7. PubMed ID: 12352904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.